Alexion Pharm Inc
(ALXN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 07-1999 | 06-1999 | 03-1999 | 12-1998 | 09-1998 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 27,950 | 21,670 | 29,600 | 31,500 |
| Marketable Securities | N/A | 5,540 | 7,590 | 4,040 | 5,980 |
| Receivables | N/A | 4,600 | 0 | 0 | 0 |
| Other current assets | 0 | 280 | 470 | 180 | 360 |
| TOTAL | $N/A | $38,370 | $29,730 | $33,820 | $37,840 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 1,460 | 1,820 | 1,850 | 1,880 |
| TOTAL | $N/A | $1,460 | $1,820 | $1,850 | $1,880 |
| Total Assets | $N/A | $46,490 | $33,970 | $38,090 | $42,080 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 2,910 | 1,070 | 760 | 810 |
| Accrued Expenses | N/A | 880 | 840 | 610 | 810 |
| Other current liabilities | N/A | 450 | 0 | 60 | 60 |
| TOTAL | $N/A | $4,610 | $2,280 | $1,810 | $2,060 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 4,470 | 640 | 740 | 830 |
| TOTAL | $N/A | $4,470 | $640 | $740 | $830 |
| Total Liabilities | $N/A | $9,080 | $2,920 | $2,550 | $2,890 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 1 | 1 | 1 | 1 |
| Retained earnings | N/A | -42,830 | -49,130 | -44,250 | -40,590 |
| Other shareholders' equity | 0 | -11 | -1 | -1 | -1 |
| TOTAL | $N/A | $37,400 | $31,040 | $35,540 | $39,190 |
| Total Liabilities And Equity | $0 | $46,480 | $33,960 | $38,090 | $42,080 |